Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.

BACKGROUND: Unilateral focused ultrasound ablation of the internal segment of globus pallidus has reduced motor symptoms of Parkinson's disease in open-label studies. METHODS: We randomly assigned, in a 3:1 ratio, patients with Parkinson's disease and dyskinesias or motor fluctuations and motor impairment in the off-medication state to undergo either focused ultrasound ablation opposite the most symptomatic side of the body or a sham procedure. The primary outcome was a response at 3 months, defined as a decrease of at least 3 points from baseline either in the score on the Movement Disorders Society-Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III), for the treated side in the off-medication state or in the score on the Unified Dyskinesia Rating Scale (UDysRS) in the on-medication state. Secondary outcomes included changes from baseline to month 3 in the scores on various parts of the MDS-UPDRS. After the 3-month blinded phase, an open-label phase lasted until 12 months. RESULTS: Of 94 patients, 69 were assigned to undergo ultrasound ablation (active treatment) and 25 to undergo the sham procedure (control); 65 patients and 22 patients, respectively, completed the primary-outcome assessment. In the active-treatment group, 45 patients (69%) had a response, as compared with 7 (32%) in the control group (difference, 37 percentage points; 95% confidence interval, 15 to 60; P = 0.003). Of the patients in the active-treatment group who had a response, 19 met the MDS-UPDRS III criterion only, 8 met the UDysRS criterion only, and 18 met both criteria. Results for secondary outcomes were generally in the same direction as those for the primary outcome. Of the 39 patients in the active-treatment group who had had a response at 3 months and who were assessed at 12 months, 30 continued to have a response. Pallidotomy-related adverse events in the active-treatment group included dysarthria, gait disturbance, loss of taste, visual disturbance, and facial weakness. CONCLUSIONS: Unilateral pallidal ultrasound ablation resulted in a higher percentage of patients who had improved motor function or reduced dyskinesia than a sham procedure over a period of 3 months but was associated with adverse events. Longer and larger trials are required to determine the effect and safety of this technique in persons with Parkinson's disease. (Funded by Insightec; ClinicalTrials.gov number, NCT03319485.).

Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkisnsonism.

Background: Magnetic resonance imaging (MRI)-guided focused ultrasound (FUS) VIM-thalamotomy has established efficacy and safety in tremor relief in patients with essential tremor and Parkinson's disease. The efficacy and safety in patients with atypical parkinsonism have not been reported. Objective: To report on the efficacy and safety of FUS VIM-thalamotomy in 8 patients with parkinsonism, multiple system atrophy-Parkinsonian type (MSA-P) (n = 5), and dementia with Lewy bodies (DLB) (n = 3). Methods: Tremor was assessed in the treated hemibody using the Clinical Rating Scale for Tremor (CRST). The motor Unified MSA Rating Scale (UMSAR) was used in the MSA-P and motor sections of the Unified Parkinson's Disease Rating Scale (UPDRS-III) in DLB patients. Cognition was measured using the Montreal Cognitive Assessment (MoCA). Results: In MSA-P and DLB patients, there was immediate tremor relief. CRST scores measured on the treated side improved compared to baseline. During the follow-up of up to 1 year tremor reduction persisted. The change in CRST scores at different time points did not reach statistical significance, probably due to the small sample size. Adverse events were transient and resolved within a year. Conclusions: In our experience, FUS VIM-thalamotomy was effective in patients with MSA-P and DLB. Larger, controlled studies are needed to verify our preliminary observations.

A Study on the Ability of Nanomaterials to Adsorb NO and SO2 from Combustion Gases and the Effectiveness of Their Separation.

Climate neutrality for the year 2050 is the goal assumed at the level of the EU27+UK. As Romania is no exception, it has assumed the gradual mitigation of pollution generated by the energy sector, and by 2030, according to 'Fit for 55', the share of energy from renewable sources must reach 42.5% from total energy consumption. For the rest of the energy produced from traditional sources, natural gas and/or coal, modern technologies will be used to retain the gaseous noxes. Even if they are not greenhouse gases, NO and SO2, generated from fossil fuel combustion, cause negative effects on the environment and biodiversity. The adsorption capacity of different materials, three nanomaterials developed in-house and three commercial adsorbents, both for NO and SO2, was tackled through gas chromatography, elemental analysis, and Fourier-transform infrared spectroscopy. Fe-BTC has proven to be an excellent material for separation efficiency and adsorption capacity under studied conditions, and is shown to be versatile both in the case of NO (80.00 cm3/g) and SO2 (63.07 cm3/g). All the developed nanomaterials generated superior results in comparison to the commercial adsorbents. The increase in pressure enhanced the performance of the absorption process, while temperature showed an opposite influence, by blocking the active centers on the surface.

Selectivity of MOFs and Silica Nanoparticles in CO2 Capture from Flue Gases.

Until reaching climate neutrality by attaining the EU 2050 level, the current levels of CO2 must be mitigated through the research and development of resilient technologies. This research explored potential approaches to lower CO2 emissions resulting from combustion fossil fuels in power plant furnaces. Different nanomaterials (MOFs versus silica nanoparticles) were used in this context to compare their effectiveness to mitigate GHG emissions. Porous materials known as metal-organic frameworks (MOFs) are frequently employed in sustainable CO2 management for selective adsorption and separation. Understanding the underlying mechanism is difficult due to their textural characteristics, the presence of functional groups and the variation in technological parameters (temperature and pressure) during CO2-selective adsorption. A silica-based nanomaterial was also employed in comparison. To systematically map CO2 adsorption as a function of the textural and compositional features of the nanomaterials and the process parameters set to a column-reactor system (CRS), 160 data points were collected for the current investigation. Different scenarios, as a function of P (bar) or as a function of T (K), were designed based on assumptions, 1 and 5 vs. 1-10 (bar) and 313.15 and 373.15 vs. 313.15-423.15 (K), where the regression analyses through Pearson coefficients of 0.92-0.95, coefficients of determination of 0.87-0.90 and p-values < 0.05, on predictive and on-site laboratory data, confirmed the performances of the CRS.

Why mortality is still high with modern care of 613 evacuated mass lesions presented as severe head injuries 1999-2009.

Of 1,949 successive acute severe head injuries (SHI) over a period of 11 years 1999-2009, 613 (31.5%) underwent evacuation of mass lesions. Mortality at 3 months of evacuated mass (EM) lesions was higher over 10 years compared with that of non-EM lesions (it was overall 22%). The reduction of mortality was significantly less in EM compared with that for non-surgical cases (14.4-9.4% recently) and for the cases that were operated but not for mass evacuation (18.1-12.1%). A few explanations are: first, more SDH (60.5% of the EM recently compared with 45.9% in the first few years); second, more severe cases and older patients with co-morbidities were treated surgically; third, advances in prehospital care brought more severe patients to operative care - the rate of referrals decreased from 61.5% to 52.8% recently; fourth, part of the significant shortening of the injury to NT admission time (163-141 min) vanished owing to the parallel elongation of admission to operation time (95-100 min), thus, the threshold recommendation of 4 h to mass evacuation was achieved in only 52%; fifth, introducing decompressive craniectomy was not associated with outcome improvement.

Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson's Disease: Long-Term Results.

BACKGROUND: MRI-guided focused ultrasound (FUS) has established short-term efficacy in tremor relief. OBJECTIVE: We report our long-term experience of treating tremor with unilateral FUS unilateral VIM-thalamotomy in tremor dominant Parkinson's disease (TDPD) patients. METHODS: We report outcome of FUS thalamotomy in TDPD patients with 1-5 years of follow-up. OUTCOMES: tremor reduction assessed with Clinical Rating Scale for Tremor (CRST) and Unified Parkinson's Disease Rating Scale (UPDRS part III) overall and in the treated hemibody and safety. RESULTS: Twenty-six TDPD patients completed 1-5 years of follow-up (median follow-up 36 months, range 12-60 months). Median age was 60 years (range 46-79), with median disease duration of 6 years (range 2-16). Immediately, treatment resulted in 100%improvement in tremor in the treated arm in 23 patients and 90%improvement in 3 patients. In 15 patients with leg tremor, 2 patients with chin tremor and 1 patient with head tremor, tremor was significantly improved. Up to 5 years, median CRST score, median UPDRS score, overall and in treated hemibody, decreased significantly as compared with baseline (p < 0.0001). In 2 patients tremor returned completely and in 8 patients there was partial return of tremor. Adverse events were mild and resolved within 3 months. At baseline 4 patients were not receiving any medication vs. 3 at last follow-up and 15 were not taking levodopa vs.9 at last follow-up. CONCLUSION: Unilateral FUS VIM-thalamotomy in TDPD patients was effective and safe and provided long-term tremor relief in most patients. FUS thalamotomy for tremor may delay initiation of levodopa treatment.

Eco-Friendly Alternative Disposal through the Pyrolysis Process of Meat and Bone Meal.

The capitalization of agri-food waste is essential for the sustainability of a circular economy. This work focuses on a solution to eliminate such waste, meat and bone meal (MBM), which is produced in large quantities by the food industry and is prohibited for use as animal feed under the European directives. Therefore, with the focus of converting waste to energy, the catalytic pyrolysis of MBM in the presence of mesoporous silica nanocatalysts (SBA-3 and SBA-16 materials and metallic derivates) was investigated in a home-made reactor for the production of renewable energy. The mesoporous silica materials were synthesized using relatively simple methods and then characterized in order to determine their morpho-structural characteristics. The MBM pyrolysis behavior under different experimental conditions was examined in detail, both in the presence and absence of the new catalysts. The resulting MBM-based pyrolysis products, MBMPYOILs and MBMPYGASs, were also assessed as potential alternative fuels, highlighting comparable energy values to conventional fuels. The outcomes of this investigation offer a potential pathway to the clean production of gas and oil, thus promoting the high-grade utilization of MBM waste.

New US device versus imaging US to assess tumor-in-brain.

BACKGROUND: Applying ultrasonic imaging system during surgery requires the poring of saline, performing the measurement, and acquiring data from its display-which requires time and is highly "performer dependent," i.e., the measure is of a subjective nature. A new ultrasonic device was recently developed that overcomes most of these drawbacks and was successfully applied during tumor-in-brain neurosurgeries. The purpose of this study was to compare the two types of US devices and demonstrate their properties. METHODS: The study was performed in the following stages: (i) an ex vivo experiment, where slices of the muscle and brain of a young porcine were laid one on top the other. Thicknesses and border depths were measured and compared, using the two types of US instruments. (ii) During human clinical neurosurgeries, tumor depth was compared by measuring it with both devices. (iii) Following the success of stages (i) and (ii), using solely the new US device, the tumor thickness was monitored while its resection.Correlation, Pearson's coefficient, average, mean, and standard deviation were applied for statistical tests. RESULTS: A high correlation was obtained for the distances of tissue borders and for their respective thicknesses. Applying these ultrasonic devices during neurosurgeries, tumor depths were monitored with high similarity (87%), which was also obtained by Pearson's correlation coefficient (0.44). The new US device, thanks to its small footprint, its remote measurement, and the capability of monitoring intraoperatively and in real-time, provides the approach to tumor's border before its complete resection. CONCLUSIONS: The new US device provides better accuracy than an ultrasonic imaging system; its data is objective; it enables to control the residual tumor thickness during its resection, and it is especially useful in restricted areas. These features were found of great help during a tumor-in-brain surgery and especially in the final stages of tumor's resection.

Magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: a 5-year single-center experience.

OBJECTIVE: The authors report their experience in treating patients suffering from medication-resistant essential tremor (ET) with MR-guided focused ultrasound (MRgFUS) thalamotomy over a 5-year period. METHODS: Forty-four ET patients treated with unilateral MRgFUS ventral intermediate nucleus (VIM) thalamotomy were assessed using the Clinical Rating Scale for Tremor (CRST) score and the Quality of Life in Essential Tremor Questionnaire (QUEST) over a 5-year span. RESULTS: Tremor was significantly improved immediately following MRgFUS in all patients and ceased completely in 24 patients. CRST scores in the treated hand at baseline (median 19; range 7-32, 44 patients) improved by a median of 16 at 1 month (44 patients; p < 0.0001), 17 at 6 months (31 patients; p < 0.0001), 15 at 1 year (24 patients; p < 0.0001), 18 at 2 years (15 patients; p < 0.0001), 19 at 3 years, (10 patients; p < 0.0001), 21 at 4 years (6 patients; p < 0.01), and 23 at 5 years (2 patients, significance not tested). Return of tremor that impacted activities of daily living was reported in 5 patients (11%). QUEST scores showed significant improvement, with median change of 35 points (p < 0.0001; 44 patients) at 1 month, 33 (p < 0.0001; 31 patients) at 6 months, 27 (p < 0.0001; 24 patients) at 1 year, 26 (p < 0.001; 15 patients) at 2 years, 25 (p < 0.001; 10 patients) at 3 years, 33 (p < 0.001; 6 patients) at 4 years, and 28 (significance not tested, 2 patients) at 5 years. Adverse events after the procedure were reversible in all but 5 patients (11%). CONCLUSIONS: MRgFUS thalamotomy for ET is an effective and safe procedure that provides long-term tremor relief and improvement in quality of life even in patients with medication-resistant disabling tremor. Additional studies with a larger group of patients is needed to substantiate these favorable results.

Homogeneity assessment for grass samples used for organically bound tritium proficiency test.

The paper presents homogeneity check for dried grass batch to be used in an inter-comparison exercise. When carrying out an inter-comparison exercise, the organizer must guarantee that the unsatisfactory result will not be imputed to the sample and sample's changeability. Therefore, in an inter-comparison exercise must carry on the homogeneity testing. In our study, the homogeneity was checked for two parameters, the hydrogen percentage (%H) and the organically bound tritium (OBT) activity concentration. Ten subsamples of 50g from bulk material were chosen using a stratified random selection. Two replicates from each package were analyzed for hydrogen content and OBT analysis. The homogeneity parameters were evaluated according to ISO 13528:2015. The two checked properties confirm that the batch of dried grass is sufficiently homogenous.

The role of advanced MR methods in the diagnosis of cerebral amyloidoma.

Amyloidoma is a term referring to a tumor-like deposition of extracellular insoluble fibrillar protein. Tumor-like amyloid formation in the brain had been described in isolated cases. However no advanced radiological studies to characterize these lesions have been reported. In the report, we have describe a 59-year-old woman, presented several months prior to diagnosis with memory decline, dizziness, walking instability, and speech difficulties. MRI revealed a left basal ganglia lesion with an intraventricular component. The patient underwent a stereotactic biopsy, which confirmed the diagnosis of amyloidoma, an extensive radiographic characterization of amyloidoma using advanced MR techniques was done, including magnetic resonance spectroscopy, dynamic susceptibility contrast, susceptibility weighted image (SWI), and magnetization transfer (MTR). All advanced MR techniques were able to characterize the amyloidoma as a non-neoplastic process. This is an example where such methods can be used for differential diagnosis of atypical brain lesions.